Product Images Fosrenol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Fosrenol NDC 54092-257 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - fosrenol 01

Figure 1 - fosrenol 01

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - fosrenol 02

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - fosrenol 02

FOSRENOL is a medication manufactured by Takeda Pharmaceuticals America, Inc. in Italy. It comes in chewable tablet form with active ingredients of 500mg of lanthanum as lanthanum carbonate hydrate. The medication guide enclosed must be given to each patient by the pharmacist. Tablets should not be swallowed whole and must be chewed or crushed completely before swallowing. It should be taken with or immediately after meals. The package insert contains complete prescribing information. The proper storage requirement is at 25°C (77°F), and excursions are permitted between 15-30°C (59-86'F).*

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Package - fosrenol 03

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Package - fosrenol 03

NDC 54092-252-90 is a prescription medicine containing lanthanum carbonate hydrate used to reduce high levels of phosphate in the blood for patients with chronic kidney disease. It comes in chewable tablet form and must not be swallowed whole. Patients should chew it completely before swallowing or take it with food. The active ingredients are colloidal silicon dioxide, dextrates, and magnesium stearate. For more information, patients should visit the website. It should be kept between 15-30°C (59-86°F) and distributed by Takeda Pharmaceuticals America, Inc., in two bottles with 45 chewable tablets each. The package insert contains full prescribing information. Pharmacists must ensure that packages are not broken.*

PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Label - fosrenol 04

PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Label - fosrenol 04

This is a medication named FOSRENOL, which consists of 750mg of lanthanum. The medication comes in the form of chewable tablets that should not be swallowed whole, and should be taken with or after meals. The inactive ingredients in the medication are colloidal silicon dioxide, dextrates, and magnesium stearate. The medication guide should be enclosed in the package, and the full prescribing information is available in the package insert. The tablets should be stored between 15-30°C (59-86°F).*

PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Package - fosrenol 05

PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Package - fosrenol 05

FOSRENOL (lanthanum carbonate) is a medication that comes in chewable tablets with 750 mg of active ingredient per tablet. It is used to control high levels of phosphorus in patients with end-stage kidney disease. The tablets should not be swallowed whole, but chewed or crushed before swallowing, and taken with or immediately after meals. This medication should be stored at temperatures between 15-30°C (59-86°F). Each package contains 6 bottles, and each bottle contains 15 chewable tablets, designed for one month of therapy. For full prescribing information, please refer to the package insert.*

PRINCIPAL DISPLAY PANEL - 1000 mg Tablet Bottle Label - fosrenol 06

PRINCIPAL DISPLAY PANEL - 1000 mg Tablet Bottle Label - fosrenol 06

This is the description of a prescription medication called FOSRENOL. It contains 1000mg of lanthanum as lanthanum carbonate hydrate and is available in chewable tablets. The product must not be swallowed whole, but chewed or crushed before swallowing. The inactive ingredients include colloidal silicon dioxide, dextrates, and starch. The medication must be taken with or immediately after meals. The package insert contains full prescribing information, and each patient is required to receive the enclosed Medication Guide. It is recommended to store the product at room temperature between 15-30°C (59-86F).*

PRINCIPAL DISPLAY PANEL - 1000 mg Tablet Bottle Package - fosrenol 07

PRINCIPAL DISPLAY PANEL - 1000 mg Tablet Bottle Package - fosrenol 07

FOSRENOL is a medication that comes in chewable tablets. Each tablet contains 1000 mg of lanthanum carbonate hydrous, alongside colloidal silicon dioxide, Gextratos, and magnesium stearate. The medication should not be swallowed whole and needs to be chewed or crushed completely before swallowing, and it is recommended to take it with or immediately after meals. The packaging insert provides full prescribing information about FOSRENOL. It is also noted that each patient package contains nine bottles, with ten chewable tablets each, designed as one month's therapy. This medication is distributed by Takeda Pharmaceuticals America, Inc., located in Lexington, MA, USA. For more information, you can visit www.fosrenol.com.*

PRINCIPAL DISPLAY PANEL - 750 mg Packet Carton - 10 Stick Pack - fosrenol 08

PRINCIPAL DISPLAY PANEL - 750 mg Packet Carton - 10 Stick Pack - fosrenol 08

Fosrenol is an oral powder medication indicated for the treatment of hyperphosphatemia in patients with end-stage renal disease. The active ingredient is lanthanum carbonate, which should be mixed with a small quantity of soft food. Fosrenol comes as stick packs with each providing 750mg of lanthanum carbonate. This medication is available only with a doctor's prescription. For complete information on this medication, refer to the package insert.*

PRINCIPAL DISPLAY PANEL - 750 mg Packet Carton - 90 Stick Pack - fosrenol 09

PRINCIPAL DISPLAY PANEL - 750 mg Packet Carton - 90 Stick Pack - fosrenol 09

Fosrenol is an oral powder medication containing Lanthanum carbonate. The recommended dose is 750 mg, which should be mixed with a small quantity of soft food and taken immediately. The medication is available in sachets containing 10 stick packs, and there are 9 cartons in total. It is manufactured in Germany and distributed in the USA. The text includes a package insert and prescription information.*

PRINCIPAL DISPLAY PANEL - 1000 mg Packet Carton - 10 Stick Pack - fosrenol 10

PRINCIPAL DISPLAY PANEL - 1000 mg Packet Carton - 10 Stick Pack - fosrenol 10

This is a medication description for Fosrenol oral powder. It is a lanthanum carbonate medication, available in 1000 mg stick packs. It must be mixed with a small quantity of food before consumption and kept at room temperature. The active ingredient is 1000 mg of lanthanum carbonate, which is present in each sick pack. The inactive ingredients include coloring agents and lubricants. The medication is available only on prescription. The manufacturer of the medication is Takace, and the medication is manufactured and distributed in Germany.*

PRINCIPAL DISPLAY PANEL - 1000 mg Packet Carton - 90 Stick Pack - fosrenol 11

PRINCIPAL DISPLAY PANEL - 1000 mg Packet Carton - 90 Stick Pack - fosrenol 11

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.